Hashimoto’s Thyroiditis Diagnosis and Treatment Market Growth, Size, Share, Industry Report and Forecast 2021-2027

 The global Hashimoto’s Thyroiditis Diagnosis and Treatment Market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The key factor to drive the market growth is the increasing prevalence of hypothyroidism among the population. For instance, Hashimoto thyroiditis also known as lymphocytic thyroiditis is the major cause of hypothyroidism in the US where it is mostly seen in women in the region. According to the American Thyroid Association, it has been estimated that around 12.0% of Americans will be developing thyroid conditions in their lifetime in which almost 20 million Americans already have some form of thyroid disease. 60.0% of the US population with thyroid disorder are not aware of their condition.  Various government organizations such as the American Thyroid Association, the British Thyroid Foundation, Thyroid Foundation of Canada partnering with many major corporate players for increasing awareness about the diseases and treatment options. For instance, the American Thyroid Association exhibits partnerships with major players such as AbbVie, Horizon, Takeda International, and others. With the help of the corporate leadership council with its partners, it enables open communication between the ATA and the community of corporations about thyroid health.

To Request a Sample of our Report on Hashimoto’s Thyroiditis Diagnosis and Treatment Market:  https://www.omrglobal.com/request-sample/hashimotos-thyroiditis-diagnosis-and-treatment-market

Rising acquisitions, collaborations among the major players in the market also propel the growth of the market. For instance, in March 2021, Merk a US-based pharma giant acquired Pandion Therapeutics for its TALON technology and immune modulators. Merk acquired Pandion for $1.85 billion and the strategy behind this acquisition was to address the unmet needs of patients suffering from autoimmune diseases. With this acquisition, Merk will be creating a pipeline of diverse candidates that will be activating the natural immune regulatory mechanisms and have chances of achieving better clinical responses for patients with such diseases.

 Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027

Segment Covered- 

  • By Diagnosis
  • By Treatment
  • By Distribution Channel

Regions Covered-

Ø  North America

Ø  Europe

Ø  Asia-Pacific

Ø  Rest of the World

  • Competitive Landscape- AbbVie Inc., Pfizer Inc, Merck KGaA, and IBSA Institute Biochimique SA

 (Get 15% Discount on Buying this Report)

A full Report of Hashimoto’s Thyroiditis Diagnosis and Treatment Market is Available at:  https://www.omrglobal.com/industry-reports/hashimotos-thyroiditis-diagnosis-and-treatment-market

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

Ø  Deviation from the pre-COVID-19 forecast

Ø  Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Hashimoto’s Thyroiditis Diagnosis and Treatment Market Report Segment

 By Diagnosis

  • Thyroid-Stimulating Hormone Test
  • Thyroxine Test
  • Antithyroid Antibody Test

By Treatment

  • Levothyroxine
  • Triiodothyronine
  • Desiccated Thyroid Extract

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies

Global Hashimoto’s Thyroiditis Diagnosis and Treatment Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of The World

  • Latin America
  • Middle East & Africa

Company Profiles 

  • AcellaPharmaceuticals, LLC
  • Allergan plc
  • Bio-Rad Laboratories, Inc.
  • General Electric Co.
  • Intas Pharmaceuticals Ltd.
  • Jerome Stevens Pharmaceuticals, Inc.
  • Lannett Company, Inc.
  • Lupin Ltd.
  • Mylan NV
  • Novartis AG
  • RLC Labs
  • Taj Pharmaceuticals Ltd.

Reasons to Buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/hashimotos-thyroiditis-diagnosis-and-treatment-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Leave a Reply

Your email address will not be published. Required fields are marked *